A child getting vaccinated.Photo: GettyModerna’s vaccine againstCOVID-19has been found to be safe and highly effective in children ages 12 to 17.On Tuesday, the companyannouncedits findings from a clinical trial, called TeenCOVE, that involved more than 3,700 kids who either received the vaccine or a placebo.Per the study, there were four cases of COVID-19 among the placebo group after two doses were administered, compared with none in the vaccine group — meaning the vaccine was 100 percent effective.“We are encouraged that [the vaccine] was highly effective at preventing COVID-19 in adolescents,” Moderna CEO Stéphane Bancel said in a statement. “It is particularly exciting to see that the Moderna COVID-19 vaccine can prevent SARS-CoV-2 infection.“Moderna plans to send those findings to theFood and Drug Administration (FDA)in early June, per a company statement.A person getting vaccinated.GettyThe news from Moderna comes shortly after the FDA said earlier this month that adolescents aged 12 to 15 are now approvedto get Pfizer-BioNTech’s COVID-19 vaccineafter a “rigorous and thorough” evaluation to ensure its safety.Prior to the FDA’s announcement, Pfizer’s vaccine was only approved for people aged 16 and up. The other two vaccines in use in the U.S., from Moderna and Johnson & Johnson, are currently allowed in ages 18 and up.“The FDA’s expansion of the emergency use authorization for the Pfizer-BioNTech COVID-19 Vaccine to include adolescents 12 through 15 years of age is a significant step in the fight against the COVID-19 pandemic,” Dr. Janet Woodcocksaid in a statementat the time. “Today’s action allows for a younger population to be protected from COVID-19, bringing us closer to returning to a sense of normalcy and to ending the pandemic.“As of May 25, more than 49% of American adults have received at least one dose of a COVID-19 vaccine, and 39.3% are now fully vaccinated against the virus,the CDC reports.New cases are also dropping significantly — infections are now averaging around 24,794 a day, a decrease of 37% over the last 14 days,according toThe New York Times.As information about thecoronavirus pandemicrapidly changes, PEOPLE is committed to providing the most recent data in our coverage. Some of the information in this story may have changed after publication. For the latest on COVID-19, readers are encouraged to use online resources from theCDC,WHOandlocal public health departments.PEOPLE has partnered with GoFundMeto raise money for the COVID-19 Relief Fund, a GoFundMe.org fundraiser to support everything from frontline responders to families in need, as well as organizations helping communities. For more information or to donate, clickhere.
A child getting vaccinated.Photo: Getty
Moderna’s vaccine againstCOVID-19has been found to be safe and highly effective in children ages 12 to 17.On Tuesday, the companyannouncedits findings from a clinical trial, called TeenCOVE, that involved more than 3,700 kids who either received the vaccine or a placebo.Per the study, there were four cases of COVID-19 among the placebo group after two doses were administered, compared with none in the vaccine group — meaning the vaccine was 100 percent effective.“We are encouraged that [the vaccine] was highly effective at preventing COVID-19 in adolescents,” Moderna CEO Stéphane Bancel said in a statement. “It is particularly exciting to see that the Moderna COVID-19 vaccine can prevent SARS-CoV-2 infection.“Moderna plans to send those findings to theFood and Drug Administration (FDA)in early June, per a company statement.A person getting vaccinated.GettyThe news from Moderna comes shortly after the FDA said earlier this month that adolescents aged 12 to 15 are now approvedto get Pfizer-BioNTech’s COVID-19 vaccineafter a “rigorous and thorough” evaluation to ensure its safety.Prior to the FDA’s announcement, Pfizer’s vaccine was only approved for people aged 16 and up. The other two vaccines in use in the U.S., from Moderna and Johnson & Johnson, are currently allowed in ages 18 and up.“The FDA’s expansion of the emergency use authorization for the Pfizer-BioNTech COVID-19 Vaccine to include adolescents 12 through 15 years of age is a significant step in the fight against the COVID-19 pandemic,” Dr. Janet Woodcocksaid in a statementat the time. “Today’s action allows for a younger population to be protected from COVID-19, bringing us closer to returning to a sense of normalcy and to ending the pandemic.“As of May 25, more than 49% of American adults have received at least one dose of a COVID-19 vaccine, and 39.3% are now fully vaccinated against the virus,the CDC reports.New cases are also dropping significantly — infections are now averaging around 24,794 a day, a decrease of 37% over the last 14 days,according toThe New York Times.As information about thecoronavirus pandemicrapidly changes, PEOPLE is committed to providing the most recent data in our coverage. Some of the information in this story may have changed after publication. For the latest on COVID-19, readers are encouraged to use online resources from theCDC,WHOandlocal public health departments.PEOPLE has partnered with GoFundMeto raise money for the COVID-19 Relief Fund, a GoFundMe.org fundraiser to support everything from frontline responders to families in need, as well as organizations helping communities. For more information or to donate, clickhere.
Moderna’s vaccine againstCOVID-19has been found to be safe and highly effective in children ages 12 to 17.
On Tuesday, the companyannouncedits findings from a clinical trial, called TeenCOVE, that involved more than 3,700 kids who either received the vaccine or a placebo.
Per the study, there were four cases of COVID-19 among the placebo group after two doses were administered, compared with none in the vaccine group — meaning the vaccine was 100 percent effective.
“We are encouraged that [the vaccine] was highly effective at preventing COVID-19 in adolescents,” Moderna CEO Stéphane Bancel said in a statement. “It is particularly exciting to see that the Moderna COVID-19 vaccine can prevent SARS-CoV-2 infection.”
Moderna plans to send those findings to theFood and Drug Administration (FDA)in early June, per a company statement.
A person getting vaccinated.Getty
The news from Moderna comes shortly after the FDA said earlier this month that adolescents aged 12 to 15 are now approvedto get Pfizer-BioNTech’s COVID-19 vaccineafter a “rigorous and thorough” evaluation to ensure its safety.
Prior to the FDA’s announcement, Pfizer’s vaccine was only approved for people aged 16 and up. The other two vaccines in use in the U.S., from Moderna and Johnson & Johnson, are currently allowed in ages 18 and up.
“The FDA’s expansion of the emergency use authorization for the Pfizer-BioNTech COVID-19 Vaccine to include adolescents 12 through 15 years of age is a significant step in the fight against the COVID-19 pandemic,” Dr. Janet Woodcocksaid in a statementat the time. “Today’s action allows for a younger population to be protected from COVID-19, bringing us closer to returning to a sense of normalcy and to ending the pandemic.”
As of May 25, more than 49% of American adults have received at least one dose of a COVID-19 vaccine, and 39.3% are now fully vaccinated against the virus,the CDC reports.
New cases are also dropping significantly — infections are now averaging around 24,794 a day, a decrease of 37% over the last 14 days,according toThe New York Times.
As information about thecoronavirus pandemicrapidly changes, PEOPLE is committed to providing the most recent data in our coverage. Some of the information in this story may have changed after publication. For the latest on COVID-19, readers are encouraged to use online resources from theCDC,WHOandlocal public health departments.PEOPLE has partnered with GoFundMeto raise money for the COVID-19 Relief Fund, a GoFundMe.org fundraiser to support everything from frontline responders to families in need, as well as organizations helping communities. For more information or to donate, clickhere.
source: people.com
